FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311633507> ?p ?o ?g. }

• W4311633507 endingPage "1674" @default.
• W4311633507 startingPage "1674" @default.
• W4311633507 abstract "Background: The severity of white matter hyperintensity (WMH) in patients with acute lacunar stroke (ALS) may be not completely parallel to cognitive impairment. Controversies persist about the effects of WMH on cognitive dysfunction. It is vital to explore whether the association may be affected by certain factors and whether a subsequent subgroup analysis is necessary. The aim of this study was to evaluate the relationship between WMH and cognitive impairment in acute lacunar stroke patients and the possible causal factors. Methods: We continuously enrolled patients with ALS who were hospitalized at the First Affiliated Hospital of Soochow University between October 2017 and June 2022. The cognitive function of all patients was assessed by using the Montreal Cognitive Assessment (MoCA) scale 14 ± 2 days after the onset of AIS, and the results were adjusted to the education level. The MoCA scale was reevaluated at the 6-month (day 182 ± 7) follow-up by outpatient visit or video. Demographic and clinical data were collected. The manifestations of chronic cerebral small-vessel disease (CSVD), including the total Fazekas score and total CSVD burden score, were assessed with an MRI scan. A mismatch refers to an inconsistency between the severity of WMH and cognitive dysfunction. A Type 1 mismatch refers to cognitive impairment with mild WMH (total Fazekas score = 0−1), and a Type 2 mismatch refers to severe WMH (total Fazekas score = 5−6) in patients with normal cognitive function. Results: Among 213 enrolled ALS patients, 66 patients (31.0%) had cognitive dysfunction, and 40 patients (18.8%) had mismatches. Twenty-seven cases (12.7%) were Type 1 mismatched, and seventeen cases (8.0%) were Type 2 mismatched. Age, gender, fibrinogen and cerebral infarction history were independent risk factors for cognitive impairment in ALS patients. Imaging features, including moderate to severe WMH, deep WMH and the total CSVD burden score, were also independently associated with cognitive impairment. The patients in the mismatched group were older, had more severe deep WMH and had a higher occurrence of depression (p < 0.05). The NIHSS score, depression and microbleeds were significantly different between the Type 1 mismatched group and the matched group (p = 0.018, p = 0.012 and p = 0.047). Patients in the Type 2 mismatched group were male (p = 0.04), had a lower level of fibrinogen (p = 0.005), a lower incidence of CMBs (p = 0.003), a lower total CSVD burden score (p = 0.017), more severe paraventricular WMH (p = 0.035) and milder deep WMH (p = 0.026). Conclusions: Our study examined a homogeneous study cohort of recruited patients with symptomatic ALS. We found heterogeneity between WMH and cognitive function in ALS patients. Despite a similar WMH severity, some baseline clinical features and other conventional CSVD imaging characteristics may account for this heterogeneity phenomenon. Our findings provide data for the early diagnosis and prevention of cognitive impairment in ALS patients and suggest that the severity of WMH is not completely parallel to cognitive impairment. The white matter microstructural injury and remote WMH effects may account for the mismatch phenomenon. More attention should be paid to understanding the underlying mechanisms and finding new imaging markers." @default.
• W4311633507 created "2022-12-27" @default.
• W4311633507 creator A5008358099 @default.
• W4311633507 creator A5025571286 @default.
• W4311633507 creator A5031674504 @default.
• W4311633507 creator A5043858232 @default.
• W4311633507 creator A5055356574 @default.
• W4311633507 creator A5065232759 @default.
• W4311633507 creator A5068337121 @default.
• W4311633507 creator A5079242000 @default.
• W4311633507 date "2022-12-06" @default.
• W4311633507 modified "2023-10-01" @default.
• W4311633507 title "Heterogeneity of White Matter Hyperintensity and Cognitive Impairment in Patients with Acute Lacunar Stroke" @default.
• W4311633507 cites W1908088802 @default.
• W4311633507 cites W1964580878 @default.
• W4311633507 cites W1972238409 @default.
• W4311633507 cites W1977357681 @default.
• W4311633507 cites W1980370294 @default.
• W4311633507 cites W1991144593 @default.
• W4311633507 cites W2002667055 @default.
• W4311633507 cites W2011689297 @default.
• W4311633507 cites W2016863118 @default.
• W4311633507 cites W2035228196 @default.
• W4311633507 cites W2054692171 @default.
• W4311633507 cites W2056460343 @default.
• W4311633507 cites W2062601898 @default.
• W4311633507 cites W2068415386 @default.
• W4311633507 cites W2071252381 @default.
• W4311633507 cites W2072290762 @default.
• W4311633507 cites W2092251781 @default.
• W4311633507 cites W2094219604 @default.
• W4311633507 cites W2096092665 @default.
• W4311633507 cites W2097547688 @default.
• W4311633507 cites W2100078230 @default.
• W4311633507 cites W2102445568 @default.
• W4311633507 cites W2103330115 @default.
• W4311633507 cites W2106430568 @default.
• W4311633507 cites W2117648794 @default.
• W4311633507 cites W2122294423 @default.
• W4311633507 cites W2122477279 @default.
• W4311633507 cites W2123715936 @default.
• W4311633507 cites W2123782121 @default.
• W4311633507 cites W2129497119 @default.
• W4311633507 cites W2133185939 @default.
• W4311633507 cites W2140621953 @default.
• W4311633507 cites W2144212512 @default.
• W4311633507 cites W2144220340 @default.
• W4311633507 cites W2144971762 @default.
• W4311633507 cites W2147245958 @default.
• W4311633507 cites W2156917318 @default.
• W4311633507 cites W2158742097 @default.
• W4311633507 cites W2162453950 @default.
• W4311633507 cites W2163788386 @default.
• W4311633507 cites W2164756048 @default.
• W4311633507 cites W2414066681 @default.
• W4311633507 cites W2543320303 @default.
• W4311633507 cites W2575508054 @default.
• W4311633507 cites W2606160933 @default.
• W4311633507 cites W2743177227 @default.
• W4311633507 cites W2761952268 @default.
• W4311633507 cites W2766387804 @default.
• W4311633507 cites W2767674851 @default.
• W4311633507 cites W2777628720 @default.
• W4311633507 cites W2790351915 @default.
• W4311633507 cites W2804435536 @default.
• W4311633507 cites W2898320157 @default.
• W4311633507 cites W2949195531 @default.
• W4311633507 cites W2995216162 @default.
• W4311633507 cites W3091760523 @default.
• W4311633507 cites W3093177082 @default.
• W4311633507 cites W3100991048 @default.
• W4311633507 cites W3111288252 @default.
• W4311633507 cites W3120750557 @default.
• W4311633507 cites W3126155937 @default.
• W4311633507 cites W3145948343 @default.
• W4311633507 cites W3159017614 @default.
• W4311633507 cites W3184676096 @default.
• W4311633507 cites W4200332029 @default.
• W4311633507 cites W4225303504 @default.
• W4311633507 cites W4232960070 @default.
• W4311633507 cites W4237376074 @default.
• W4311633507 cites W4242811236 @default.
• W4311633507 doi "https://doi.org/10.3390/brainsci12121674" @default.
• W4311633507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36552134" @default.
• W4311633507 hasPublicationYear "2022" @default.
• W4311633507 type Work @default.
• W4311633507 citedByCount "1" @default.
• W4311633507 countsByYear W43116335072023 @default.
• W4311633507 crossrefType "journal-article" @default.
• W4311633507 hasAuthorship W4311633507A5008358099 @default.
• W4311633507 hasAuthorship W4311633507A5025571286 @default.
• W4311633507 hasAuthorship W4311633507A5031674504 @default.
• W4311633507 hasAuthorship W4311633507A5043858232 @default.
• W4311633507 hasAuthorship W4311633507A5055356574 @default.
• W4311633507 hasAuthorship W4311633507A5065232759 @default.
• W4311633507 hasAuthorship W4311633507A5068337121 @default.
• W4311633507 hasAuthorship W4311633507A5079242000 @default.
• W4311633507 hasBestOaLocation W43116335071 @default.

• next